Company / PP&E (Net)
RxSight, Inc. PP&E (Net) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$13.1M
FY2025
5-year range
$10.1M / $13.1M
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has increased for 3 consecutive years, from $10M in FY2022 to $13M in FY2025.
Based on SEC 10-K filings.
$13M in FY2025 with a 3-year CAGR of +8.8%.
Improved from $11M to $13M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- RxSight, Inc.'s pp&e (net) has grown for 3 consecutive years.
- 3-year CAGR of +8.8%, indicating consistent growth.
- In FY2025, pp&e (net) increased 5.2% year-over-year.
- Lowest pp&e (net) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.59 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.1M | +5.2% |
| FY2024 | $12.4M | +14.5% |
| FY2023 | $10.8M | +6.9% |
| FY2022 | $10.1M | -9.6% |
| FY2021 | $11.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026